These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9110396)

  • 1. Quality of life and health economics: where is the link?
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 221():33-6. PubMed ID: 9110396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.
    Gafni A
    Am J Manag Care; 1997 May; 3 Suppl():S21-32. PubMed ID: 10180338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis in dermatology.
    Ellis CN; Reiter KL; Wheeler JR; Fendrick AM
    J Am Acad Dermatol; 2002 Feb; 46(2):271-83. PubMed ID: 11807441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-utility analysis from a societal perspective.
    Johannesson M; O'Conor RM
    Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating quality of life changes into economic evaluations of health care: an overview.
    Blumenschein K; Johannesson M
    Health Policy; 1996 May; 36(2):155-66. PubMed ID: 10158766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the use of health status measures in economic evaluation.
    Brazier J; Deverill M; Green C
    J Health Serv Res Policy; 1999 Jul; 4(3):174-84. PubMed ID: 10538884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
    Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
    Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
    [No Abstract]   [Full Text] [Related]  

  • 8. Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.
    Labelle RJ; Hurley JE
    J Health Econ; 1992 Oct; 11(3):259-77. PubMed ID: 10122539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic evaluation of health care.
    Haas M; Hall J
    Health Inf Manag; 1998 Dec-1999 Feb; 28(4):169-72. PubMed ID: 10387363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?
    Birch S; Gafni A
    J Health Econ; 1992 Oct; 11(3):279-96. PubMed ID: 10122540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of condition specific outcome measures in economic appraisal.
    Brazier J; Dixon S
    Health Econ; 1995; 4(4):255-64. PubMed ID: 8528428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where are the economic guidelines coming from?
    McGuire A; Morris S; Raikou M
    Int J Technol Assess Health Care; 2000; 16(4):976-86. PubMed ID: 11155846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensively Measuring Health-Related Subjective Well-Being: Dimensionality Analysis for Improved Outcome Assessment in Health Economics.
    de Vries M; Emons WH; Plantinga A; Pietersma S; van den Hout WB; Stiggelbout AM; van den Akker-van Marle ME
    Value Health; 2016; 19(2):167-75. PubMed ID: 27021750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of economic measures used in menorrhagia: a systematic review.
    Sanghera S; Frew E; Kai J; Gupta J; Elizabeth Roberts T
    Soc Sci Med; 2013 Dec; 98():149-53. PubMed ID: 24331893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 17. The Hanover Consensus: helpful for German decision-makers?
    Kolominsky-Rabas PL; Caro JJ
    Value Health; 2008; 11(4):545-6; discussion 547-8. PubMed ID: 18489522
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternatives to the QALY measure for economic evaluations.
    Gafni A
    Support Care Cancer; 1997 Mar; 5(2):105-11. PubMed ID: 9069609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of health producing measures across different sectors.
    Drummond M; Stoddart G
    Health Policy; 1995 Sep; 33(3):219-31. PubMed ID: 10145123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost-utility analyses.
    Rankin J; Rowen D; Howe A; Cleland JGF; Whitty JA
    Heart Fail Rev; 2019 Jul; 24(4):549-563. PubMed ID: 30903357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.